Conference
Post-Hoc Analysis of RE-MEDY (TM) Demonstrates Significant Real-World Net Clinical Benefit for Dabigatran Versus Warfarin in Prevention of Secondary Venous Thromboembolism
Authors
Schulman S; Eriksson H; Kakkar A; Kearon C; Schellong SM; Mismetti P; Feuring M; Hantel S; Kreuzer J; Goldhaber SZ
Volume
124
Publisher
AMER SOC HEMATOLOGY
Publication Date
December 6, 2014
Name of conference
56th Annual Meeting and Exposition of the American-Society-of-Hematology
Conference place
San Francisco, CA
Conference start date
December 6, 2014
Conference end date
December 9, 2014
Conference proceedings
BLOOD
Issue
21
ISSN
0006-4971